Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project.
Hedberg P, Parczewski M, Serwin K, Marchetti G, Bai F, Ole Jensen BE, Pereira JPV, Drobniewski F, Reschreiter H, Naumovas D, Ceccherini-Silberstein F, Rubio Quintanares GH, Mwau M, Toscano C, König F, Pfeifer N, Zazzi M, Fanti I, Incardona F, Cozzi-Lepri A, Sönnerborg A, Nauclér P. Hedberg P, et al. Among authors: ole jensen be. Lancet Reg Health Eur. 2024 Feb 2;38:100855. doi: 10.1016/j.lanepe.2024.100855. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38476753 Free PMC article.
Disease Course and Pulmonary Involvement of COVID-19 during the Delta Variant Period in Germany: A Comparative Study of Vaccinated and Unvaccinated Patients at a Tertiary Hospital.
Steuwe A, Ljimani A, Andree M, Wienemann T, Lübke N, Walker A, Ole Jensen BE, The Racoon Study Group, Radke KL, Antoch G, Valentin B. Steuwe A, et al. Among authors: ole jensen be. Curr Med Imaging. 2024 Feb 26. doi: 10.2174/0115734056282920231212104602. Online ahead of print. Curr Med Imaging. 2024. PMID: 38415484
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome.
Rüthrich MM, Khodamoradi Y, Lanznaster J, Stecher M, Tometten L, Voit F, Koll CEM, Borgmann S, Vehreschild JJ, Ole Jensen BE, Hanses F, Giessen-Jung C, Wille K, von Lilienfeld-Toal M, Beutel G; LEOSS Study Group. Rüthrich MM, et al. Among authors: ole jensen be. Oncol Res Treat. 2024;47(3):88-96. doi: 10.1159/000535267. Epub 2023 Nov 15. Oncol Res Treat. 2024. PMID: 37967545 Free article.
Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19-A Case Series.
Groiss SJ, Balloff C, Elben S, Brandenburger T, Müttel T, Kindgen-Milles D, Vollmer C, Feldt T, Kunstein A, Ole Jensen BE, Hartung HP, Schnitzler A, Albrecht P. Groiss SJ, et al. Among authors: ole jensen be. Front Neurol. 2020 Nov 5;11:574004. doi: 10.3389/fneur.2020.574004. eCollection 2020. Front Neurol. 2020. PMID: 33224088 Free PMC article.
Reducing Hematologic Toxicity With Short Course Postexposure Prophylaxis With Zidovudine for HIV-1 Exposed Infants With Low Transmission Risk.
Nguyen TTT, Kobbe R, Schulze-Sturm U, Blohm M, Hollwitz B, Hertling S, Becker C, Oommen PT, Laws HJ, Martignoni F, Ole Jensen BE, Olah K, Schmidtke S, Kreuels B, Vasconcelos MK, Neubert J. Nguyen TTT, et al. Among authors: ole jensen be. Pediatr Infect Dis J. 2019 Jul;38(7):727-730. doi: 10.1097/INF.0000000000002357. Pediatr Infect Dis J. 2019. PMID: 31033907
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group. Pett SL, et al. Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5. Clin Infect Dis. 2016. PMID: 27048747 Free PMC article. Clinical Trial.
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G; SINGLE Investigators. Walmsley SL, et al. N Engl J Med. 2013 Nov 7;369(19):1807-18. doi: 10.1056/NEJMoa1215541. N Engl J Med. 2013. PMID: 24195548 Free article. Clinical Trial.